Edward Chang of Pledge Capital presented his in-depth investment thesis on Nuance Communications (US: NUAN) at Best Ideas 2021.

Thesis summary:

Nuance is the market leader in software-driven voice transcription for physicians and has introduced game-changing technology in this industry. The company has the largest database of domain-specific audio in healthcare, built over two decades. Utilizing this data, Nuance is creating the best natural language processing algorithm in the industry.

Doctors at major hospital chains are already using the company’s game-changing Ambient Clinical Intelligence (ACI) software offering — called Dragon Ambient eXperience (DAX). This subscription service listens to a doctor-patient conversation and automatically constructs a physician note. Early users are reporting a significant reduction in time spent on administrative tasks, which frees them to see more patients or leave work earlier than in the past.

Edward believes the company is only in the first inning of developing and commercializing this new technology.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Edward Chang is the founder and Portfolio Manager at Pledge Capital. He is a graduate of New York University Leonard N. Stern School of Business with a Bachelor’s degree in Finance & Accounting. He also completed a Master’s degree in accounting during the same time. Before founding Pledge Capital in 2016, he worked on the sell side at UBS Equity Research covering consumer retail companies. He had previous work experience covering a wide breadth of companies on the buy-side.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.